Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors - Concepedia

Concepedia

Publication | Closed Access

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

47

Citations

20

References

2007

Year

Wandena S. Siegel-Lakhai, Jos H. Beijnen, Walter L. Vervenne, Henk Boot, Marianne Keessen, M. Versola, Kevin M. Koch, Deborah A. Smith, Lini Pandite, D. J. Richel,

Clinical Cancer Research

Abstract

Lapatinib can be safely administered in combination with the standard FOLFOX4 regimen. Further studies are warranted to explore the potential additive antitumor effect of lapatinib in combination with the FOLFOX4 regimen.

References

	Year	Citations

Page 1